← Back to Search

Dietary Intervention

Quality-of-Life Assessment for Breast Cancer

N/A
Waitlist Available
Led By Joanne Mortimer
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 6 months
Awards & highlights

Study Summary

This trial is studying a pancreatic nutritional program to help overweight or obese breast cancer patients lose weight and improve their overall health.

Eligible Conditions
  • Breast Cancer
  • Obesity

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in body weight
Secondary outcome measures
Change in body chemistry (lipid panel; comprehensive metabolic panel; complete blood count; fasting blood glucose; insulin resistance)
Change in body composition (BMI)
Change in physical fitness (measured using a handgrip dynamometer)
+5 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Supportive care (PNP)Experimental Treatment4 Interventions
Patients participate in the PNP intervention, which begins with a baseline meeting with a diet and lifestyle instructor to discuss baseline testing results, begin an educational plan, determine an individualized eating plan, and print out food choices. Patients also undergo automated glucometry every 15 minutes, review their individual food choices and blood glucose levels 90 minutes after eating, keep a daily nutrition and lifestyle journal log, fill out a daily meal discovery card log, and attend weekly meetings with a diet and lifestyle instructor for 12 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dietary Intervention
2014
Completed Phase 2
~2550

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,648 Previous Clinical Trials
40,931,723 Total Patients Enrolled
940 Trials studying Breast Cancer
1,543,360 Patients Enrolled for Breast Cancer
City of Hope Medical CenterLead Sponsor
565 Previous Clinical Trials
1,921,332 Total Patients Enrolled
43 Trials studying Breast Cancer
6,649 Patients Enrolled for Breast Cancer
Joanne MortimerPrincipal InvestigatorCity of Hope Medical Center
6 Previous Clinical Trials
154 Total Patients Enrolled
1 Trials studying Breast Cancer
18 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still vacancies in this research endeavor?

"According to clinicaltrials.gov, the recruitment for this medical study has been concluded since it was last updated on March 17th 2022. While no longer accepting patients, there are 3,409 other studies currently seeking participants."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast Cancer
2016. "Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02432950.
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top